Apogee Therapeutics (APGE) is up 14.5%, or $5.78 to $45.51.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APGE:
- Apogee Therapeutics initiated with an Outperform at RBC Capital
- Wall Street Sees Massive Growth Potential in These 3 Russell 2000 Stocks
- 3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts
- Apogee Therapeutics price target raised to $87 from $78 at BofA
- Promising Prospects for Apogee Therapeutics: Buy Rating Backed by Strong Trial Results and Financial Health